To further explore the clinical significance of these hub genes (SUGP1, DHX16, FUS, HNRNPR, DHX15, NAA38, SKIV2L2, and PLRG1), we used a series of online tools to evaluate the clinical expression of these hub genes in leukemia. This evidence concerns the gene NAA38 and leukemia.